-
2
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Partridge E.E., Look K.Y., Clarke-Pearson D.L., Davidson M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N. Engl. J Med. 1996, 334:1-6.
-
(1996)
N. Engl. J Med.
, vol.334
, pp. 1-6
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
Kucera, P.R.4
Partridge, E.E.5
Look, K.Y.6
Clarke-Pearson, D.L.7
Davidson, M.8
-
3
-
-
70350157197
-
Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer
-
Schwartz P.E. Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer. Curr. Oncol. Rep. 2009, 11:457-465.
-
(2009)
Curr. Oncol. Rep.
, vol.11
, pp. 457-465
-
-
Schwartz, P.E.1
-
4
-
-
0018387446
-
Promotion of microtubule assembly in vitro by taxol
-
Schiff P.B., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature 1979, 277:665-667.
-
(1979)
Nature
, vol.277
, pp. 665-667
-
-
Schiff, P.B.1
Fant, J.2
Horwitz, S.B.3
-
5
-
-
0000297058
-
Taxol stabilizes microtubules in mouse fibroblast cells
-
Schiff P.B., Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA. 1980, 77:1561-1565.
-
(1980)
Proc. Natl. Acad. Sci. USA.
, vol.77
, pp. 1561-1565
-
-
Schiff, P.B.1
Horwitz, S.B.2
-
6
-
-
0028801693
-
-
NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer, Jama.
-
NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer, Jama. 273 (1995) 491-497.
-
(1995)
, vol.273
, pp. 491-497
-
-
-
7
-
-
2542547908
-
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation
-
Kondapaka S.B., Singh S.S., Dasmahapatra G.P., Sausville E.A., Roy K.K. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol. Cancer Ther. 2003, 2:1093-1103.
-
(2003)
Mol. Cancer Ther.
, vol.2
, pp. 1093-1103
-
-
Kondapaka, S.B.1
Singh, S.S.2
Dasmahapatra, G.P.3
Sausville, E.A.4
Roy, K.K.5
-
8
-
-
0033563010
-
Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis
-
Ruiter G.A., Zerp S.F., Bartelink H., van Blitterswijk W.J., Verheij M. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res. 1999, 59:2457-2463.
-
(1999)
Cancer Res.
, vol.59
, pp. 2457-2463
-
-
Ruiter, G.A.1
Zerp, S.F.2
Bartelink, H.3
van Blitterswijk, W.J.4
Verheij, M.5
-
9
-
-
0037331989
-
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway
-
Ruiter G.A., Zerp S.F., Bartelink H., van Blitterswijk W.J., Verheij M. Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs. 2003, 14:167-173.
-
(2003)
Anticancer Drugs.
, vol.14
, pp. 167-173
-
-
Ruiter, G.A.1
Zerp, S.F.2
Bartelink, H.3
van Blitterswijk, W.J.4
Verheij, M.5
-
10
-
-
0036494382
-
Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest
-
Patel V., Lahusen T., Sy T., Sausville E.A., Gutkind J.S., Senderowicz A.M. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Cancer Res. 2002, 62:1401-1409.
-
(2002)
Cancer Res.
, vol.62
, pp. 1401-1409
-
-
Patel, V.1
Lahusen, T.2
Sy, T.3
Sausville, E.A.4
Gutkind, J.S.5
Senderowicz, A.M.6
-
11
-
-
0036345448
-
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours
-
Crul M., Rosing H., de Klerk G.J., Dubbelman R., Traiser M., Reichert S., Knebel N.G., Schellens J.H., Beijnen J.H., ten Bokkel Huinink W.W. Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours. Eur. J Cancer. 2002, 38:1615-1621.
-
(2002)
Eur. J Cancer.
, vol.38
, pp. 1615-1621
-
-
Crul, M.1
Rosing, H.2
de Klerk, G.J.3
Dubbelman, R.4
Traiser, M.5
Reichert, S.6
Knebel, N.G.7
Schellens, J.H.8
Beijnen, J.H.9
ten Bokkel Huinink, W.W.10
-
12
-
-
9344270514
-
A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer
-
Van Ummersen L., Binger K., Volkman J., Marnocha R., Tutsch K., Kolesar J., Arzoomanian R., Alberti D., Wilding G. A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer. Clin. Cancer Res. 2004, 10:7450-7456.
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 7450-7456
-
-
Van Ummersen, L.1
Binger, K.2
Volkman, J.3
Marnocha, R.4
Tutsch, K.5
Kolesar, J.6
Arzoomanian, R.7
Alberti, D.8
Wilding, G.9
-
13
-
-
33645047901
-
Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts
-
Vink S.R., Lagerwerf S., Mesman E., Schellens J.H., Begg A.C., van Blitterswijk W.J., Verheij M. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts. Clin. Cancer Res. 2006, 12:1615-1622.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 1615-1622
-
-
Vink, S.R.1
Lagerwerf, S.2
Mesman, E.3
Schellens, J.H.4
Begg, A.C.5
van Blitterswijk, W.J.6
Verheij, M.7
-
14
-
-
15944406971
-
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species
-
Rahmani M., Reese E., Dai Y., Bauer C., Payne S.G., Dent P., Spiegel S., Grant S. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. Cancer Res. 2005, 65:2422-2432.
-
(2005)
Cancer Res.
, vol.65
, pp. 2422-2432
-
-
Rahmani, M.1
Reese, E.2
Dai, Y.3
Bauer, C.4
Payne, S.G.5
Dent, P.6
Spiegel, S.7
Grant, S.8
-
15
-
-
31544448038
-
Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells
-
Li X., Luwor R., Lu Y., Liang K., Fan Z. Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells. Oncogene 2006, 25:525-535.
-
(2006)
Oncogene
, vol.25
, pp. 525-535
-
-
Li, X.1
Luwor, R.2
Lu, Y.3
Liang, K.4
Fan, Z.5
-
16
-
-
77956227529
-
C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro
-
Yu T., Li J., Sun H. C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro. Cancer Chemother. Pharmacol. 2010, 66:999-1003.
-
(2010)
Cancer Chemother. Pharmacol.
, vol.66
, pp. 999-1003
-
-
Yu, T.1
Li, J.2
Sun, H.3
-
17
-
-
0038333197
-
Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop
-
von Haefen C., Wieder T., Essmann F., Schulze-Osthoff K., Dorken B., Daniel P.T. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. Oncogene 2003, 22:2236-2247.
-
(2003)
Oncogene
, vol.22
, pp. 2236-2247
-
-
von Haefen, C.1
Wieder, T.2
Essmann, F.3
Schulze-Osthoff, K.4
Dorken, B.5
Daniel, P.T.6
-
18
-
-
14844333242
-
Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3
-
Chen T., Pengetnze Y., Taylor C.C. Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3. Mol. Cancer Ther. 2005, 4:217-224.
-
(2005)
Mol. Cancer Ther.
, vol.4
, pp. 217-224
-
-
Chen, T.1
Pengetnze, Y.2
Taylor, C.C.3
-
19
-
-
33644643243
-
Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death
-
Qiu L., Di W., Jiang Q., Scheffler E., Derby S., Yang J., Kouttab N., Wanebo H., Yan B., Wan Y. Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death. Int. J Oncol. 2005, 27:1441-1448.
-
(2005)
Int. J Oncol.
, vol.27
, pp. 1441-1448
-
-
Qiu, L.1
Di, W.2
Jiang, Q.3
Scheffler, E.4
Derby, S.5
Yang, J.6
Kouttab, N.7
Wanebo, H.8
Yan, B.9
Wan, Y.10
-
20
-
-
2442534189
-
Induction of surviving expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest
-
Ling X., Bernacki R.J., Brattain M.G., Li F. Induction of surviving expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. J Biol. Chem. 2004, 279:15196-15203.
-
(2004)
J Biol. Chem.
, vol.279
, pp. 15196-15203
-
-
Ling, X.1
Bernacki, R.J.2
Brattain, M.G.3
Li, F.4
-
21
-
-
14844303304
-
Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization
-
Bava S.V., Puliappadamba V.T., Deepti A., Nair A., Karunagaran D., Anto R.J. Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J Biol. Chem. 2005, 280:6301-6308.
-
(2005)
J Biol. Chem.
, vol.280
, pp. 6301-6308
-
-
Bava, S.V.1
Puliappadamba, V.T.2
Deepti, A.3
Nair, A.4
Karunagaran, D.5
Anto, R.J.6
-
22
-
-
33646577479
-
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
-
Hideshima T., Catley L., Yasui H., Ishitsuka K., Raje N., Mitsiades C., Podar K., Munshi N.C., Chauhan D., Richardson P.G., Anderson K.C. Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood 2006, 107:4053-4062.
-
(2006)
Blood
, vol.107
, pp. 4053-4062
-
-
Hideshima, T.1
Catley, L.2
Yasui, H.3
Ishitsuka, K.4
Raje, N.5
Mitsiades, C.6
Podar, K.7
Munshi, N.C.8
Chauhan, D.9
Richardson, P.G.10
Anderson, K.C.11
-
23
-
-
33747819801
-
MTOR and cancer: insights into a complex relationship
-
Sabatini D.M. mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 2006, 6:729-734.
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 729-734
-
-
Sabatini, D.M.1
-
24
-
-
34249828179
-
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs
-
Swanton C., Marani M., Pardo O., Warne P.H., Kelly G., Sahai E., Elustondo F., Chang J., Temple J., Ahmed A.A., Brenton J.D., Downward J., Nicke B. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell. 2007, 11:498-512.
-
(2007)
Cancer Cell.
, vol.11
, pp. 498-512
-
-
Swanton, C.1
Marani, M.2
Pardo, O.3
Warne, P.H.4
Kelly, G.5
Sahai, E.6
Elustondo, F.7
Chang, J.8
Temple, J.9
Ahmed, A.A.10
Brenton, J.D.11
Downward, J.12
Nicke, B.13
-
25
-
-
0035032521
-
Taxol-induced ceramide generation and apoptosis in human breast cancer cells
-
Charles A.G., Han T.Y., Liu Y.Y., Hansen N., Giuliano A.E., Cabot M.C. Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother. Pharmacol. 2001, 47:444-450.
-
(2001)
Cancer Chemother. Pharmacol.
, vol.47
, pp. 444-450
-
-
Charles, A.G.1
Han, T.Y.2
Liu, Y.Y.3
Hansen, N.4
Giuliano, A.E.5
Cabot, M.C.6
-
26
-
-
0027787984
-
Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ
-
Merrill A.H., van Echten G., Wang E., Sandhoff K. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol. Chem. 1993, 268:27299-27306.
-
(1993)
J Biol. Chem.
, vol.268
, pp. 27299-27306
-
-
Merrill, A.H.1
van Echten, G.2
Wang, E.3
Sandhoff, K.4
-
27
-
-
0032561366
-
Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK)
-
Lee L.F., Li G., Templeton D.J., Ting J.P. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J Biol. Chem. 1998, 273:28253-28260.
-
(1998)
J Biol. Chem.
, vol.273
, pp. 28253-28260
-
-
Lee, L.F.1
Li, G.2
Templeton, D.J.3
Ting, J.P.4
-
28
-
-
0033583321
-
Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells
-
Wang T.H., Popp D.M., Wang H.S., Saitoh M., Mural J.G., Henley D.C., Ichijo H., Wimalasena J. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol. Chem. 1999, 274:8208-8216.
-
(1999)
J Biol. Chem.
, vol.274
, pp. 8208-8216
-
-
Wang, T.H.1
Popp, D.M.2
Wang, H.S.3
Saitoh, M.4
Mural, J.G.5
Henley, D.C.6
Ichijo, H.7
Wimalasena, J.8
-
29
-
-
0035923665
-
SP600125 an anthrapyrazolone inhibitor of Jun N-terminal kinase
-
Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125 an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 2001, 98:13681-13686.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 13681-13686
-
-
Bennett, B.L.1
Sasaki, D.T.2
Murray, B.W.3
O'Leary, E.C.4
Sakata, S.T.5
Xu, W.6
Leisten, J.C.7
Motiwala, A.8
Pierce, S.9
Satoh, Y.10
Bhagwat, S.S.11
Manning, A.M.12
Anderson, D.W.13
-
30
-
-
78650303774
-
Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition
-
Ji C., Yang B., Yang Y.L., He S.H., Miao D.S., He L., Bi Z.G. Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene 2010, 29:6557-6568.
-
(2010)
Oncogene
, vol.29
, pp. 6557-6568
-
-
Ji, C.1
Yang, B.2
Yang, Y.L.3
He, S.H.4
Miao, D.S.5
He, L.6
Bi, Z.G.7
-
31
-
-
77954809178
-
Ceramide: from lateral segregation to mechanical stress
-
Lopez-Montero I., Monroy F., Velez M., Devaux P.F. Ceramide: from lateral segregation to mechanical stress. Biochim. Biophys. Acta 2010, 1798:1348-1356.
-
(2010)
Biochim. Biophys. Acta
, vol.1798
, pp. 1348-1356
-
-
Lopez-Montero, I.1
Monroy, F.2
Velez, M.3
Devaux, P.F.4
-
32
-
-
77649122069
-
Ceramide and ceramide 1-phosphate in health and disease
-
Arana L., Gangoiti P., Ouro A., Trueba M., Gomez-Munoz A. Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis. 2010, 9:15.
-
(2010)
Lipids Health Dis.
, vol.9
, pp. 15
-
-
Arana, L.1
Gangoiti, P.2
Ouro, A.3
Trueba, M.4
Gomez-Munoz, A.5
-
33
-
-
42649126006
-
Ceramide-induced cell death in malignant cells
-
Carpinteiro A., Dumitru C., Schenck M., Gulbins E. Ceramide-induced cell death in malignant cells. Cancer Lett. 2008, 264:1-10.
-
(2008)
Cancer Lett.
, vol.264
, pp. 1-10
-
-
Carpinteiro, A.1
Dumitru, C.2
Schenck, M.3
Gulbins, E.4
-
34
-
-
78049510823
-
Cancer treatment strategies targeting sphingolipid metabolism
-
Oskouian B., Saba J.D. Cancer treatment strategies targeting sphingolipid metabolism. Adv. Exp. Med. Biol. 2010, 688:185-205.
-
(2010)
Adv. Exp. Med. Biol.
, vol.688
, pp. 185-205
-
-
Oskouian, B.1
Saba, J.D.2
-
35
-
-
33744749249
-
Ceramide in apoptotic signaling and anticancer therapy
-
Lin C.F., Chen C.L., Lin Y.S. Ceramide in apoptotic signaling and anticancer therapy. Curr. Med. Chem. 2006, 13:1609-1616.
-
(2006)
Curr. Med. Chem.
, vol.13
, pp. 1609-1616
-
-
Lin, C.F.1
Chen, C.L.2
Lin, Y.S.3
-
36
-
-
0347537940
-
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
-
Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996, 380:75-79.
-
(1996)
Nature
, vol.380
, pp. 75-79
-
-
Verheij, M.1
Bose, R.2
Lin, X.H.3
Yao, B.4
Jarvis, W.D.5
Grant, S.6
Birrer, M.J.7
Szabo, E.8
Zon, L.I.9
Kyriakis, J.M.10
Haimovitz-Friedman, A.11
Fuks, Z.12
Kolesnick, R.N.13
-
37
-
-
0029148660
-
Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals
-
Bose R., Verheij M., Haimovitz-Friedman A., Scotto K., Fuks Z., Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995, 82:405-414.
-
(1995)
Cell
, vol.82
, pp. 405-414
-
-
Bose, R.1
Verheij, M.2
Haimovitz-Friedman, A.3
Scotto, K.4
Fuks, Z.5
Kolesnick, R.6
-
38
-
-
0032211769
-
Signal transduction of stress via ceramide
-
Mathias S., Pena L.A., Kolesnick R.N. Signal transduction of stress via ceramide. Biochem. J. 1998, 335(Pt 3):465-480.
-
(1998)
Biochem. J.
, vol.335
, Issue.PART 3
, pp. 465-480
-
-
Mathias, S.1
Pena, L.A.2
Kolesnick, R.N.3
-
39
-
-
0033897314
-
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line
-
Mehta S., Blackinton D., Omar I., Kouttab N., Myrick D., Klostergaard J., Wanebo H. Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother. Pharmacol. 2000, 46:85-92.
-
(2000)
Cancer Chemother. Pharmacol.
, vol.46
, pp. 85-92
-
-
Mehta, S.1
Blackinton, D.2
Omar, I.3
Kouttab, N.4
Myrick, D.5
Klostergaard, J.6
Wanebo, H.7
-
40
-
-
34547619923
-
Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells
-
Qiu L., Zhou C., Sun Y., Di W., Scheffler E., Healey S., Wanebo H., Kouttab N., Chu W., Wan Y. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. Oncol. Rep. 2006, 16:907-913.
-
(2006)
Oncol. Rep.
, vol.16
, pp. 907-913
-
-
Qiu, L.1
Zhou, C.2
Sun, Y.3
Di, W.4
Scheffler, E.5
Healey, S.6
Wanebo, H.7
Kouttab, N.8
Chu, W.9
Wan, Y.10
-
41
-
-
0028981358
-
Ceramide activates the stress-activated protein kinases
-
Westwick J.K., Bielawska A.E., Dbaibo G., Hannun Y.A., Brenner D.A. Ceramide activates the stress-activated protein kinases. J Biol. Chem. 1995, 270:22689-22692.
-
(1995)
J Biol. Chem.
, vol.270
, pp. 22689-22692
-
-
Westwick, J.K.1
Bielawska, A.E.2
Dbaibo, G.3
Hannun, Y.A.4
Brenner, D.A.5
-
42
-
-
0032411879
-
Stress signals for apoptosis: ceramide and c-Jun kinase
-
Basu S., Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene. 1998, 17:3277-3285.
-
(1998)
Oncogene.
, vol.17
, pp. 3277-3285
-
-
Basu, S.1
Kolesnick, R.2
-
43
-
-
1542618348
-
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
-
Shaw R.J., Kosmatka M., Bardeesy N., Hurley R.L., Witters L.A., DePinho R.A., Cantley L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA. 2004, 101:3329-3335.
-
(2004)
Proc. Natl. Acad. Sci. USA.
, vol.101
, pp. 3329-3335
-
-
Shaw, R.J.1
Kosmatka, M.2
Bardeesy, N.3
Hurley, R.L.4
Witters, L.A.5
DePinho, R.A.6
Cantley, L.C.7
-
44
-
-
34247898927
-
Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells
-
Kim Y.M., Hwang J.T., Kwak D.W., Lee Y.K., Park O.J. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann. NY Acad. Sci. 2007, 1095:496-503.
-
(2007)
Ann. NY Acad. Sci.
, vol.1095
, pp. 496-503
-
-
Kim, Y.M.1
Hwang, J.T.2
Kwak, D.W.3
Lee, Y.K.4
Park, O.J.5
-
45
-
-
72449153399
-
Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells
-
Kim do Y., Park M.W., Yuan H.D., Lee H.J., Kim S.H., Chung S.H. Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells. J Agric. Food Chem. 2009, 57:10573-10578.
-
(2009)
J Agric. Food Chem.
, vol.57
, pp. 10573-10578
-
-
Kim do, Y.1
Park, M.W.2
Yuan, H.D.3
Lee, H.J.4
Kim, S.H.5
Chung, S.H.6
-
46
-
-
69149097363
-
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
-
Guo D., Hildebrandt I.J., Prins R.M., Soto H., Mazzotta M.M., Dang J., Czernin J., Shyy J.Y., Watson A.D., Phelps M., Radu C.G., Cloughesy T.F., Mischel P.S. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc. Natl. Acad. Sci. USA 2009, 106:12932-12937.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 12932-12937
-
-
Guo, D.1
Hildebrandt, I.J.2
Prins, R.M.3
Soto, H.4
Mazzotta, M.M.5
Dang, J.6
Czernin, J.7
Shyy, J.Y.8
Watson, A.D.9
Phelps, M.10
Radu, C.G.11
Cloughesy, T.F.12
Mischel, P.S.13
-
47
-
-
20844449238
-
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
-
Jones R.G., Plas D.R., Kubek S., Buzzai M., Mu J., Xu Y., Birnbaum M.J., Thompson C.B. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 2005, 18:283-293.
-
(2005)
Mol. Cell
, vol.18
, pp. 283-293
-
-
Jones, R.G.1
Plas, D.R.2
Kubek, S.3
Buzzai, M.4
Mu, J.5
Xu, Y.6
Birnbaum, M.J.7
Thompson, C.B.8
-
48
-
-
42949152052
-
Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress
-
Okoshi R., Ozaki T., Yamamoto H., Ando K., Koida N., Ono S., Koda T., Kamijo T., Nakagawara A., Kizaki H. Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J Biol. Chem. 2008, 283:3979-3987.
-
(2008)
J Biol. Chem.
, vol.283
, pp. 3979-3987
-
-
Okoshi, R.1
Ozaki, T.2
Yamamoto, H.3
Ando, K.4
Koida, N.5
Ono, S.6
Koda, T.7
Kamijo, T.8
Nakagawara, A.9
Kizaki, H.10
-
49
-
-
3543025724
-
AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
-
Xiang X., Saha A.K., Wen R., Ruderman N.B., Luo Z. AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms. Biochem. Biophys. Res. Commun. 2004, 321:161-167.
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.321
, pp. 161-167
-
-
Xiang, X.1
Saha, A.K.2
Wen, R.3
Ruderman, N.B.4
Luo, Z.5
-
50
-
-
0037430753
-
5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells
-
Garcia-Gil M., Pesi R., Perna S., Allegrini S., Giannecchini M., Camici M., Tozzi M.G. 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 2003, 117:811-820.
-
(2003)
Neuroscience
, vol.117
, pp. 811-820
-
-
Garcia-Gil, M.1
Pesi, R.2
Perna, S.3
Allegrini, S.4
Giannecchini, M.5
Camici, M.6
Tozzi, M.G.7
-
51
-
-
59249092573
-
AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells
-
Pan W., Yang H., Cao C., Song X., Wallin B., Kivlin R., Lu S., Hu G., Di W., Wan Y. AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells. Oncol. Rep. 2008, 20:1553-1559.
-
(2008)
Oncol. Rep.
, vol.20
, pp. 1553-1559
-
-
Pan, W.1
Yang, H.2
Cao, C.3
Song, X.4
Wallin, B.5
Kivlin, R.6
Lu, S.7
Hu, G.8
Di, W.9
Wan, Y.10
-
52
-
-
57649231164
-
AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes
-
Cao C., Lu S., Kivlin R., Wallin B., Card E., Bagdasarian A., Tamakloe T., Chu W.M., Guan K.L., Wan Y. AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J Biol. Chem. 2008, 283:28897-28908.
-
(2008)
J Biol. Chem.
, vol.283
, pp. 28897-28908
-
-
Cao, C.1
Lu, S.2
Kivlin, R.3
Wallin, B.4
Card, E.5
Bagdasarian, A.6
Tamakloe, T.7
Chu, W.M.8
Guan, K.L.9
Wan, Y.10
-
53
-
-
0038363852
-
AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase
-
Kefas B.A., Cai Y., Ling Z., Heimberg H., Hue L., Pipeleers D., Van de Casteele M. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol. Endocrinol. 2003, 30:151-161.
-
(2003)
J Mol. Endocrinol.
, vol.30
, pp. 151-161
-
-
Kefas, B.A.1
Cai, Y.2
Ling, Z.3
Heimberg, H.4
Hue, L.5
Pipeleers, D.6
Van de Casteele, M.7
-
54
-
-
0037189947
-
Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells
-
Meisse D., Van de Casteele M., Beauloye C., Hainault I., Kefas B.A., Rider M.H., Foufelle F., Hue L. Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett. 2002, 526:38-42.
-
(2002)
FEBS Lett.
, vol.526
, pp. 38-42
-
-
Meisse, D.1
Van de Casteele, M.2
Beauloye, C.3
Hainault, I.4
Kefas, B.A.5
Rider, M.H.6
Foufelle, F.7
Hue, L.8
-
55
-
-
67649363838
-
Parameters of protection against ultraviolet radiation-induced skin cell damage
-
Cao C., Wan Y. Parameters of protection against ultraviolet radiation-induced skin cell damage. J Cell. Physiol. 2009, 220:277-284.
-
(2009)
J Cell. Physiol.
, vol.220
, pp. 277-284
-
-
Cao, C.1
Wan, Y.2
-
56
-
-
77951834544
-
-
Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells, Lab Invest.
-
L. Chen, B. Xu, L. Liu, Y. Luo, J. Yin, H. Zhou, W. Chen, T. Shen, X. Han, S. Huang, Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells, Lab Invest. 90 762-773.
-
, vol.90
, pp. 762-773
-
-
Chen, L.1
Xu, B.2
Liu, L.3
Luo, Y.4
Yin, J.5
Zhou, H.6
Chen, W.7
Shen, T.8
Han, X.9
Huang, S.10
-
57
-
-
46349091235
-
AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway
-
Lee Y.M., Uhm K.O., Lee E.S., Kwon J., Park S.H., Kim H.S. AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway. Biochem. Biophys. Res. Commun. 2008, 370:641-645.
-
(2008)
Biochem. Biophys. Res. Commun.
, vol.370
, pp. 641-645
-
-
Lee, Y.M.1
Uhm, K.O.2
Lee, E.S.3
Kwon, J.4
Park, S.H.5
Kim, H.S.6
-
58
-
-
0035929359
-
Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line
-
Imamura K., Ogura T., Kishimoto A., Kaminishi M., Esumi H. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 2001, 287:562-567.
-
(2001)
Biochem. Biophys. Res. Commun.
, vol.287
, pp. 562-567
-
-
Imamura, K.1
Ogura, T.2
Kishimoto, A.3
Kaminishi, M.4
Esumi, H.5
-
59
-
-
42949139481
-
AMPK phosphorylation of raptor mediates a metabolic checkpoint
-
Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30:214-226.
-
(2008)
Mol. Cell
, vol.30
, pp. 214-226
-
-
Gwinn, D.M.1
Shackelford, D.B.2
Egan, D.F.3
Mihaylova, M.M.4
Mery, A.5
Vasquez, D.S.6
Turk, B.E.7
Shaw, R.J.8
-
60
-
-
79955019824
-
Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell
-
Chen M.B., Shen W.X., Yang Y., Wu X.Y., Gu J.H., Lu P.H. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell. J Cell Physiol. 2011, 226:1915-1925.
-
(2011)
J Cell Physiol.
, vol.226
, pp. 1915-1925
-
-
Chen, M.B.1
Shen, W.X.2
Yang, Y.3
Wu, X.Y.4
Gu, J.H.5
Lu, P.H.6
-
61
-
-
79958244812
-
Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 Cells
-
Chen M.B., Wu X.Y., Gu J.H., Guo Q.T., Shen W.X., Lu P.H. Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 Cells. Cell Biochem. Biophys. 2011, 60:311-322.
-
(2011)
Cell Biochem. Biophys.
, vol.60
, pp. 311-322
-
-
Chen, M.B.1
Wu, X.Y.2
Gu, J.H.3
Guo, Q.T.4
Shen, W.X.5
Lu, P.H.6
|